AbbVie's product recalls
2 official recall notices between Nov 2023 and Jun 2026 were matched to AbbVie.
Each notice concerns the specific products, sizes and lot codes it names. A recall does not mean that other AbbVie products are affected, and a count of notices is not a measure of safety: one incident can produce a notice for every pack size.
Covers only notices from the U.S. Food and Drug Administration enforcement reports (openFDA), USDA Food Safety and Inspection Service recalls, UK Food Standards Agency food alerts and U.S. Consumer Product Safety Commission recalls that could be matched to AbbVie: the recalling firm must be AbbVie, a parent or a subsidiary, and for a brand the brand name must appear in the product description. Method.
2026 (1)
| Date | Product | Brand | Recalling firm | Reason given | Source |
|---|---|---|---|---|---|
| PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064,… | — | AbbVie Inc. | Failed Stability Specifications Class III | FDA |
2023 (1)
| Date | Product | Brand | Recalling firm | Reason given | Source |
|---|---|---|---|---|---|
| Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11 | — | AbbVie Inc. | Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg… Class III | FDA |
Product descriptions and reasons are shortened from the regulators' own text; the linked notice is the authoritative record. See all matched recalls, or report a wrong match through the corrections page.